COVID-19: Information on ASPIRA LABS Operations

Click to Learn More

News Article

Aspira Women’s Health, Inc. to Present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum

AUSTIN, Texas — November 05, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it has been invited to present at the Canaccord Genuity Virtual MedTech & Diagnostics Forum, taking place Thursday, November 19, 2020.

Aspira Women’s Health is scheduled to present on Thursday, November 19th at 9:00amET. The presentation will be webcast live and available for replay. Registration to view a webcast of  the presentation can be found at:

This conference is open only to clients of Canaccord Genuity.

To receive additional information about Canaccord Genuity, please contact Nadine Miller, Managing Director, Global Head of Marketing & Communications at [email protected].